share_log

4: Statement of changes in beneficial ownership of securities-Director FIELD PAUL

4: Statement of changes in beneficial ownership of securities-Director FIELD PAUL

4:持股变动声明-董事 FIELD PAUL
美股SEC公告 ·  05/21 20:25
Moomoo AI 已提取核心信息
On May 16, 2024, Paul Field, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of common stock at a transaction price of $0.223 per share. Following this transaction, Field's direct holdings in the company increased to a total of 14,000 shares. The transaction, which is categorized as an exercise or conversion of derivative security, reflects Field's investment activity in the company's stock and is part of the insider trading disclosures required by regulatory authorities.
On May 16, 2024, Paul Field, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of common stock at a transaction price of $0.223 per share. Following this transaction, Field's direct holdings in the company increased to a total of 14,000 shares. The transaction, which is categorized as an exercise or conversion of derivative security, reflects Field's investment activity in the company's stock and is part of the insider trading disclosures required by regulatory authorities.
2024年5月16日,与60度制药相关的保罗·菲尔德以每股0.223美元的交易价格完成了对4,000股普通股的收购。在这笔交易之后,菲尔德在该公司的直接持股量增加到总计14,000股。该交易被归类为衍生证券的行使或转换,反映了菲尔德对公司股票的投资活动,是监管机构要求的内幕交易披露的一部分。
2024年5月16日,与60度制药相关的保罗·菲尔德以每股0.223美元的交易价格完成了对4,000股普通股的收购。在这笔交易之后,菲尔德在该公司的直接持股量增加到总计14,000股。该交易被归类为衍生证券的行使或转换,反映了菲尔德对公司股票的投资活动,是监管机构要求的内幕交易披露的一部分。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息